INIS
therapy
100%
insulin
100%
sensitivity
80%
lipids
60%
levels
40%
liver
40%
patients
40%
interactions
40%
plasma
40%
doses
20%
values
20%
fibers
20%
drugs
20%
correlations
20%
design
20%
muscles
20%
mitochondria
20%
blood pressure
20%
respiration
20%
carnitine
20%
Keyphrases
Randomized Controlled Trial
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Resveratrol
100%
Add-on Therapy
100%
Insulin Sensitivity
18%
Peripheral Insulin Sensitivity
18%
Hepatic Insulin Sensitivity
18%
Resveratrol Supplementation
18%
Metformin
18%
Hepatic Fat
18%
Placebo
9%
Mitochondrial Function
9%
Plasma Parameters
9%
Drug-naïve Patients
9%
Respiration
9%
Metabolic Health
9%
Pre-diabetes (pre-DM)
9%
Hyperinsulinemic-euglycemic Clamp
9%
Systolic Blood Pressure
9%
Type 2 Diabetic Patients
9%
Type 2 Diabetes Prevention
9%
Randomized Double-blind Crossover Study
9%
Malate
9%
Diabetes Management
9%
Dihydroresveratrol
9%
L-carnitine
9%
Clamping Method
9%
Insulin Sensitizers
9%
Intercellular Lipid
9%
Type II muscle Fibers
9%
Function States
9%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Resveratrol
100%
Add on Therapy
100%
Non Insulin Dependent Diabetes Mellitus
100%
Metformin
15%
Placebo
7%
Carnitine
7%
Impaired Glucose Tolerance
7%
Malic Acid
7%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Resveratrol
100%
Insulin Sensitivity
30%
Lipid
23%
Blood Level
7%
Systolic Blood Pressure
7%
Impaired Glucose Tolerance
7%
Blood Plasma
7%
Neuroscience
Randomized Controlled Trial
100%
Resveratrol
100%
Metformin
15%
Blood Plasma
15%
Carnitine
7%
Mitochondrial Function
7%
Placebo
7%
Crossover Study
7%
Immunology and Microbiology
Insulin Sensitivity
100%
Blood Level
25%
Blood Plasma
25%
Systolic Blood Pressure
25%
Insulin
25%
Muscle
25%